REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
14/07/2025
Voltar para busca
Dado oficial do USPTO
CELLESTIA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
CELLESTIA
ST13
US500000079246636Classe
1, 5, 42
Pedido
79246636
Registro
6098248
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
36
Atualização mais recente
15/07/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
01/11/2018
Data de registro
14/07/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
14/07/2020
Última transação
15/07/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
25
Localização do titular
CH
Examinador
EISNACH, MICHAEL
Unidade examinadora
L40
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Cellestia Biotech AG
Representantes
Anthony E. Bennett HOFFMANN & BARON, LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical products for use in industry and sciencechemicals for use in the manufacture of pharmaceutical and veterinary products; Chemicals for use in biotechnological product development
Classe 5
Pharmaceutical and veterinary productsfor the treatment of cancer and for regenerative medicine; pharmaceutical preparations for the treatment of cancerleukemialymphomainflammatory diseasesliver diseaseslung diseasescardio diseasesvascular diseasesgenetic disorders and immunity disorders; pharmaceutical productsnamely small molecule drugs for the treatment of cancer; pharmaceutical products for the treatment of NOTCH-dependent cancers; medicinal preparations for the treatment of cancerleukemialymphomainflammatory diseasesliver diseaseslung diseasescardio diseasesvascular diseasesgenetic disorders and immunity disorders; veterinary medicines for the treatment of cancerleukemialymphomainflammatory diseasesliver diseaseslung diseasescardio diseasesvascular diseasesgenetic disorders and immunity disorders; chemical and pharmaceutical preparations for the treatment of cancerleukemialymphomainflammatory diseasesliver diseaseslung diseasescardio diseasesvascular diseasesgenetic disorders and immunity disorders; diagnostic preparations for medical use; chemical and pharmaceutical preparations for veterinary use for the treatment of cancerleukemialymphomainflammatory diseasesliver diseaseslung diseasescardio diseasesvascular diseasesgenetic disorders and immunity disorders
Classe 42
Scientific and technological servicesscientific research and development in the field of pharmaceuticals; researchdevelopment of products and quality control in the field of pharmacy; research in the field of chemistry and biology; industrial analysis and research services in the field of pharmaceuticals; research and development of pharmaceutical and veterinary products; chemical analysis and research in the field of pharmaceuticals
Publicações
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
21/11/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/11/2020
FIMP
FINAL DISPOSITION PROCESSED
03/11/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
14/10/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
14/07/2020
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
04/06/2020
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
15/05/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
29/04/2020
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
29/04/2020
CHPB
POST PUBLICATION AMENDMENT - ENTERED
26/03/2020
APET
ASSIGNED TO PETITION STAFF
25/03/2020
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
24/02/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
24/02/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
24/02/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
24/02/2020
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
22/10/2019
GPNX
NOTIFICATION PROCESSED BY IB
05/10/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/09/2019
PUBO
PUBLISHED FOR OPPOSITION
24/09/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
18/09/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
18/09/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/09/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
19/08/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/08/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/08/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/08/2019
RFNP
REFUSAL PROCESSED BY IB
08/03/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
20/02/2019
RFRR
REFUSAL PROCESSED BY MPU
20/02/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/02/2019
CNRT
NON-FINAL ACTION WRITTEN
07/02/2019
DOCK
ASSIGNED TO EXAMINER
07/02/2019
MAFR
APPLICATION FILING RECEIPT MAILED
04/12/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/11/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
29/11/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CELLESTIA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.